These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy. Vurucu S; Demirkaya E; Kul M; Unay B; Gul D; Akin R; Gokçay E Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):844-8. PubMed ID: 18234410 [TBL] [Abstract][Full Text] [Related]
23. Alterations in the carnitine metabolism in epileptic children treated with valproic acid. Chung S; Choi J; Hyun T; Rha Y; Bae C J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096 [TBL] [Abstract][Full Text] [Related]
24. The influence of anticonvulsants on fasting plasma ammonia and amino acid levels. Verity CM; Applegarth DA; Farrell K; Kirby LT Clin Biochem; 1983 Dec; 16(6):344-5. PubMed ID: 6420086 [TBL] [Abstract][Full Text] [Related]
25. Serum total amylase, pancreatic amylase and lipase activities in epileptic children treated with sodium valproate monotherapy. Voudris K; Attilakos A; Katsarou E; Mastroyianni S; Dimou S; Skardoutsou A; Prassouli A; Garoufi A Brain Dev; 2006 Oct; 28(9):572-5. PubMed ID: 16730152 [TBL] [Abstract][Full Text] [Related]
26. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet. Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041 [TBL] [Abstract][Full Text] [Related]
27. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy. Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265 [TBL] [Abstract][Full Text] [Related]
28. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine. Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044 [TBL] [Abstract][Full Text] [Related]
29. Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Attilakos A; Papakonstantinou E; Schulpis K; Voudris K; Katsarou E; Mastroyianni S; Garoufi A Epilepsy Res; 2006 Oct; 71(2-3):229-32. PubMed ID: 16889940 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children. Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762 [TBL] [Abstract][Full Text] [Related]
31. Amino acid cerebrospinal fluid/plasma ratios in children: influence of age, gender, and antiepileptic medication. Scholl-Bürgi S; Haberlandt E; Heinz-Erian P; Deisenhammer F; Albrecht U; Sigl SB; Rauchenzauner M; Ulmer H; Karall D Pediatrics; 2008 Apr; 121(4):e920-6. PubMed ID: 18332074 [TBL] [Abstract][Full Text] [Related]
32. Safety and tolerability of the ketogenic diet in pediatric epilepsy: effects of valproate combination therapy. Lyczkowski DA; Pfeifer HH; Ghosh S; Thiele EA Epilepsia; 2005 Sep; 46(9):1533-8. PubMed ID: 16146450 [TBL] [Abstract][Full Text] [Related]
33. Hyperamino-acidaemia and hyperammonaemia in epileptic children treated with valproic acid. Iinuma K; Hayasaka K; Narisawa K; Tada K; Hori K Eur J Pediatr; 1988 Dec; 148(3):267-9. PubMed ID: 3145882 [TBL] [Abstract][Full Text] [Related]
34. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy. Attilakos A; Voudris KA; Katsarou E; Prassouli A; Mastroyianni S; Garoufi A Clin Neuropharmacol; 2007; 30(3):145-9. PubMed ID: 17545749 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acid. Peker E; Oktar S; Ari M; Kozan R; Doğan M; Cağan E; Söğüt S Brain Res; 2009 Nov; 1297():194-7. PubMed ID: 19703427 [TBL] [Abstract][Full Text] [Related]
36. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Aycicek A; Iscan A Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706 [TBL] [Abstract][Full Text] [Related]
37. The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate. Cansu A; Serdaroğlu A; Camurdan O; Hirfanoğlu T; Bideci A; Gücüyener K Epilepsia; 2006 Nov; 47(11):1855-9. PubMed ID: 17116024 [TBL] [Abstract][Full Text] [Related]
38. Carnitine deficiency during valproic acid treatment. Van Wouwe JP Int J Vitam Nutr Res; 1995; 65(3):211-4. PubMed ID: 8830002 [TBL] [Abstract][Full Text] [Related]
39. Ammonia and carnitine concentrations in children treated with sodium valproate compared with other anticonvulsant drugs. Thom H; Carter PE; Cole GF; Stevenson KL Dev Med Child Neurol; 1991 Sep; 33(9):795-802. PubMed ID: 1936631 [TBL] [Abstract][Full Text] [Related]
40. Effects of acute valproic acid administration on carnitine plasma concentrations in epileptic patients. Riva R; Zaccara G; Albani F; Galli G; Campostrini R; Paganini M; Baruzzi A Epilepsy Res; 1991 Mar; 8(2):149-52. PubMed ID: 2065643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]